Severe cardiomyopathy following treatment with the tumour necrosis factor-alpha inhibitor adalimumab for Crohn's disease.

Autor: Emmert MY, Salzberg SP, Emmert LS, Behjati S, Plass A, Felix C, Falk V, Gruenenfelder J
Zdroj: European Journal of Heart Failure; Nov2009, Vol. 11 Issue 11, p1106-1109, 4p
Databáze: Complementary Index
Externí odkaz: